synimmune.de valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title SYNIMMUNE GmbH:
Description SYNIMMUNE GmbH is a biotechnology company focusing on the development of novel mono- and bispecific antibodies for improved immunotherapy
Keywords SYNIMMUNE, bispecific, antibody, monoclonal, therapeutic, immunotherapy, hematopoietic
Server Information
WebSite synimmune faviconsynimmune.de
Host IP 185.15.195.231
Location Germany
Related Websites
Site Rank
More to Explore
syntech.software
szmhw.net
tablespoonfoods.com
tabtotab.com
tacfab.com
tacticals.org
tadmin.org
tajcaterers.com
tajrelocations.com
takeassignmenthelp.com
takochat.com
tales-from-a-security-professional.com
talodfoods.com
talonsecurityservice.com
tamilkalam.org
tamilxxkathai.online
tanwarindustries.com
tanwj.com
tara-enterprises.com
targetmediapr.com
synimmune.de Valuation
US$753,595
Last updated: 2022-07-01 23:58:26

synimmune.de has Semrush global rank of 14,045,085. synimmune.de has an estimated worth of US$ 753,595, based on its estimated Ads revenue. synimmune.de receives approximately 86,954 unique visitors each day. Its web server is located in Germany, with IP address 185.15.195.231. According to SiteAdvisor, synimmune.de is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$753,595
Daily Ads Revenue US$696
Monthly Ads Revenue US$20,869
Yearly Ads Revenue US$250,426
Daily Unique Visitors 5,797
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
synimmune.de. A 86398 IP: 185.15.195.231
synimmune.de. NS 86400 NS Record: b.ns14.net.
synimmune.de. NS 86400 NS Record: d.ns14.net.
synimmune.de. NS 86400 NS Record: c.ns14.net.
synimmune.de. NS 86400 NS Record: a.ns14.net.
synimmune.de. MX 86400 MX Record: 50 mx4.agenturserver.de.
synimmune.de. MX 86400 MX Record: 10 mx2.agenturserver.de.
synimmune.de. MX 86400 MX Record: 10 mx1.agenturserver.de.
synimmune.de. MX 86400 MX Record: 20 mx3.agenturserver.de.
HtmlToTextCheckTime:2022-07-01 23:58:26
Skip to navigation Skip to content Welcome NEWS Company Management Board Advisory Board Investors Technology Fc-optimized antibodies Bispecific antibodies SYNIMMUNE’s Bispecific Antibody Platform Products Product Pipeline FLYSYN TACSYN Partnering Home » Welcome Welcome to SYNIMMUNE SYNIMMUNE GmbH is a biotechnology company dedicated to the development of innovative and effective mono- and bispecific anti-tumor antibodies for the treatment of patients suffering from life-threatening diseases, with a focus on orphan hematopoietic malignancies. SYNIMMUNE’s lead product candidate is the antibody FLYSYN, which is currently in a first-in-human phase I clinical study in acute myeloid leukemia (AML). SYNIMMUNE GmbH is a spin-off of the Department of Immunology of the University of Tuebingen. The Company is financed by grants from the German Ministry of Education and Research (BMBF) within its GO-Bio program as well as investments by the German KfW and private equity. For AML Patients
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Oct 2021 16:51:27 GMT
Server: Apache
Set-Cookie: fe_typo_user=04916b7bc95c83e3843687cbfd400adc; path=/
Upgrade: h2,h2c
Connection: Upgrade
Location: https://www.synimmune.de/
Content-Type: text/html

HTTP/2 301 
date: Wed, 27 Oct 2021 16:51:27 GMT
server: Apache
set-cookie: fe_typo_user=df90f62908c8c05a8d06a84d8adb9a21; path=/
location: https://www.synimmune.de/welcome/
content-type: text/html

HTTP/2 200 
date: Wed, 27 Oct 2021 16:51:28 GMT
server: Apache
expires: Wed, 27 Oct 2021 23:45:26 GMT
cache-control: max-age=24838
pragma: public
set-cookie: fe_typo_user=b011f3f0d04dea27730c7c95297c27b0; path=/
last-modified: Wed, 15 Sep 2021 10:55:57 GMT
etag: "1b7cc448c7bc80be110ddf5ad2c6fed4"
content-type: text/html; charset=utf-8